Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 10
1984 37
1985 71
1986 49
1987 58
1988 108
1989 112
1990 146
1991 177
1992 217
1993 268
1994 257
1995 319
1996 250
1997 321
1998 340
1999 572
2000 528
2001 605
2002 458
2003 650
2004 642
2005 1057
2006 1343
2007 1222
2008 1169
2009 1445
2010 1358
2011 1586
2012 1358
2013 1200
2014 1196
2015 1324
2016 1101
2017 1267
2018 1274
2019 1300
2020 381
Text availability
Article attribute
Article type
Publication date

Search Results

22,714 results
Results by year
Filters applied: . Clear all
Page 1
The future of vaccine development.
Koff WC and Schenkelberg T. Vaccine 2019. PMID 31443989
However, vaccine development has been less successful against complex infectious diseases, where pathogen variability and/or immune evasion mechanisms have combined to pose major obstacles, and have been unsuccessful against non-communicable diseases, including cancer, autoimmunity, allergy, neurodegenerative and metabolic diseases (Koff et al., 2013) [2]. In addition, the current state of vaccine development is an expensive, slow and laborious process, costing billions of dollars, taking decades, with less than a 10% rate of success (Pronker et al., 2013) [3]. ...
However, vaccine development has been less successful against complex infectious diseases, where pathogen variability and/or immune e …
Beliefs around childhood vaccines in the United States: A systematic review
Gidengil C, et al. Vaccine 2019 - Review. PMID 31562000 Free PMC article.
Study designs, population characteristics, vaccine types, and vaccine beliefs were abstracted. We conducted a qualitative analysis to conceptualize beliefs into themes and generated descriptive statistics. ...Many of the studies that did so, focused on HPV vaccine. Concerns about vaccine safety were the most commonly stated beliefs about childhood vaccines, likely because studies were designed to capture barriers and challenges to vaccination....
Study designs, population characteristics, vaccine types, and vaccine beliefs were abstracted. We conducted a qualitative anal …
Editorial
Cravioto A. Vaccine 2019. PMID 31564303 Free article.
Vaccine-related advertising in the Facebook Ad Archive.
Jamison AM, et al. Vaccine 2020. PMID 31732327 Free PMC article.
RESULTS: 309 advertisements were included in analysis with 163 (53%) pro-vaccine advertisements and 145 (47%) anti-vaccine advertisements. ...Thematically, anti-vaccine advertising messages are relatively uniform and emphasize vaccine harms (55%). In contrast, pro-vaccine advertisements come from a diverse set of buyers (83 unique) with varied goals including promoting vaccination (49%), vaccine related philanthropy (15%), and vaccine related policy (14%). ...
RESULTS: 309 advertisements were included in analysis with 163 (53%) pro-vaccine advertisements and 145 (47%) anti-vaccine adv …
Introducing rotavirus vaccine in the Universal Immunization Programme in India: From evidence to policy to implementation.
Malik A, et al. Vaccine 2019 - Review. PMID 31474519 Free PMC article.
RESULTS: India introduced rotavirus vaccine in a phased wise manner. In the first two phases the vaccine has been introduced in nine states of the country accounting for nearly 35% of the annual birth cohort of the country. From March 2016 to November 2017, approximately 13,260,000 rotavirus vaccine doses were administered in the country. The vaccine was well accepted by both the health workers and parents/caregivers. ...
RESULTS: India introduced rotavirus vaccine in a phased wise manner. In the first two phases the vaccine has been introduced i …
Vaccine hesitancy and self-vaccination behaviors among nurses in southeastern France.
Wilson R, et al. Vaccine 2020. PMID 31810781
BACKGROUND: Health care worker vaccine uptake rates are below official targets, and studies demonstrate some are vaccine hesitant. ...Self-reported vaccine coverage ranged from 27% (seasonal influenza vaccine, recommended, 2016/17 season) to 96% (Bacillus Calmette-Guérin vaccine, mandatory). ...
BACKGROUND: Health care worker vaccine uptake rates are below official targets, and studies demonstrate some are vaccine hesit …
Adenoviral vector-based vaccine is fully protective against lethal Lassa fever challenge in Hartley guinea pigs.
Maruyama J, et al. Vaccine 2019. PMID 31561999 Free PMC article.
There is currently no licensed vaccine and there are limited animal models to test vaccine efficacy. An estimated 37.7 million people are at risk of contracting LASV; therefore, there is an urgent need for the development of a safe, effective vaccine against LASV infection. ...The Ad5 (E1-,E2b-) LASV-NP and LASV-GPC vaccine represents a potential vaccine candidate against LF....
There is currently no licensed vaccine and there are limited animal models to test vaccine efficacy. An estimated 37.7 million …
22,714 results
Jump to page
Feedback